17
Jun

Both Pfizer and Novartis have picked up the FDA’s much-coveted breakthrough-therapy designation for their meningitis B vaccines, and now the rivals have chosen the same day to submit their injections for approval, leaving it up to regulators which will hit the market first.

…read more

Source: Pfizer, Novartis race to market with ‘breakthrough’ meningitis B vaccines

    

0 No comments